ASCO 2022: Radiographic Progression in the Absence of PSA Progression in Patients with mHSPC: Post Hoc Analysis of ARCHES
Patterns of progression from ARCHES
Related Articles
Public Health Interventions and Overdose-Related Outcomes Among Persons With OUD
This decision analytical model estimates the projected 3-year association between public health interventions and opioid overdose-related outcomes among persons with opioid use disorder (OUD).
Sleep like a bear
Reduced expression of a platelet protein protects against thrombosis during chronic immobilization
AI hallucinations will be solvable within a year, ex-Google AI researcher says—but that may not be a good thing
“We want them to propose things that are weird and novel.”
unDOCumented — On Becoming an Undocumented Doctor in the United States | NEJM
This Graphic Perspective follows a “Dreamer” as he pursues his dream of becoming a physician in the United States — and faces the limits of…
Delirium Linked to a Threefold Increased Risk for Dementia
The association, which increased with subsequent episodes of delirium, was strongest in men.
Yellowstone Lake ice cover unchanged despite warming climate
While most lakes around the world are experiencing shorter durations of ice cover, the length of time that Yellowstone Lake is covered by ice each…
Axicabtagene Ciloleucel Leads to ‘Continued Durable Responses’ in Indolent B-Cell Lymphoma in ZUMA-5 | Blood Cancers Today
Axicabtagene ciloleucel led to “continued durable responses” in patients with relapsed/refractory indolent non-Hodgkin lymphoma in the ZUMA-5 trial.
What doctors wish patients knew about the deadly risk of stroke
During a stroke, every second counts. That is why it is important to know and recognize symptoms early. Two physicians share more.
Telehealth firm Cerebral fined $7 million over “careless” privacy violations
Cerebral used private patient info for TikTok advertising.
TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP
A novel approach to renal denervation led to improvements in ambulatory BP, but not office-based, in this sham-controlled trial.
